[ Price : $8.95]
Gilead Sciences recalls one lot of Veklury (remdesivir) for injection 100 mg/vial, after it received a customer complaint about th...[ Price : $8.95]
FDA has appointed industry veteran and consultant Ross Segan as CDRH Office of Product Evaluation and Quality director, replacing ...[ Price : $8.95]
Ideaya Biosciences says it is advancing darovasertib into a Phase 3 trial following positive interim Phase 2 clinical trial data o...[ Price : $8.95]
Federal Register notice: FDA makes available three draft guidances for its Accreditation Scheme for Conformity Assessment Program.[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Chemical Analysis for Biocompatibility Assessment of Medica...[ Price : $8.95]
FDA approves UCBs Bimzelx (bimekizumab-bkzx) for treating adults with active psoriatic arthritis, active non-radiographic axial sp...[ Price : $8.95]
Federal Register notice: FDA withdraws approval of nine no-longer-marketed ANDAs from multiple applicants.[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection revision entitled Postmarketing Adverse Experience Report...